Reuters logo
Pacira pain drug succeeds in late-stage trial
February 27, 2014 / 12:10 PM / 4 years ago

Pacira pain drug succeeds in late-stage trial

Feb 27 (Reuters) - Pacira Pharmaceuticals Inc said a late-stage trial testing its drug Exparel for a wider use showed the treatment significantly reduced pain compared to placebo in knee surgery patients.

Exparel is already approved for use in managing post-surgical pain when administered directly at the site of the pain. The latest trial was testing Exparel’s efficacy when applied to a major nerve adjacent to the site of the surgery, thereby blocking any sensation until the nerve endings.

A late-stage trial testing the drug, Exparel, showed that patients taking the medicine experienced significant reduction in pain over 72 hours.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below